<?xml version="1.0" encoding="UTF-8"?>
<compound>
  <id type="integer">342875</id>
  <title nil="true"/>
  <common-name>5-o-(2-prop-2-enoxyethyl) 3-o-(2-propoxyethyl) 2-(hydroxymethyl)-6-methyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate</common-name>
  <description>5-o-(2-prop-2-enoxyethyl) 3-o-(2-propoxyethyl) 2-(hydroxymethyl)-6-methyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate has the chemical formula C25H32N2O9. With an average molecular weight of 504.50 g/mol, 5-o-(2-prop-2-enoxyethyl) 3-o-(2-propoxyethyl) 2-(hydroxymethyl)-6-methyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate is a heavy molecule.</description>
  <cas>85387-16-2</cas>
  <pubchem-id>3069846</pubchem-id>
  <chemical-formula>C25H32N2O9</chemical-formula>
  <weight>504.5</weight>
  <appearance nil="true"/>
  <melting-point nil="true"/>
  <boiling-point nil="true"/>
  <density nil="true"/>
  <solubility nil="true"/>
  <specific-gravity nil="true"/>
  <flash-point nil="true"/>
  <vapour-pressure nil="true"/>
  <route-of-exposure nil="true"/>
  <target nil="true"/>
  <mechanism-of-toxicity nil="true"/>
  <metabolism nil="true"/>
  <toxicity nil="true"/>
  <lethaldose nil="true"/>
  <carcinogenicity nil="true"/>
  <use-source nil="true"/>
  <min-risk-level nil="true"/>
  <health-effects nil="true"/>
  <symptoms nil="true"/>
  <treatment nil="true"/>
  <created-at type="dateTime">2026-08-31T04:04:38Z</created-at>
  <updated-at type="dateTime">2026-08-31T04:04:38Z</updated-at>
  <interacting-proteins nil="true"/>
  <wikipedia nil="true"/>
  <uniprot-id nil="true"/>
  <kegg-compound-id nil="true"/>
  <omim-id nil="true"/>
  <chebi-id nil="true"/>
  <biocyc-id nil="true"/>
  <ctd-id nil="true"/>
  <stitch-id nil="true"/>
  <drugbank-id nil="true"/>
  <pdb-id nil="true"/>
  <actor-id nil="true"/>
  <organism nil="true"/>
  <export type="boolean">true</export>
  <metabolizing-proteins nil="true"/>
  <transporting-proteins nil="true"/>
  <moldb-smiles>CCCOCCOC(=O)C1=C(NC(=C(C1C2=CC(=CC=C2)[N+](=O)[O-])C(=O)OCCOCC=C)C)CO</moldb-smiles>
  <moldb-formula>C25H32N2O9</moldb-formula>
  <moldb-inchi>InChI=1S/C25H32N2O9/c1-4-9-33-11-13-35-24(29)21-17(3)26-20(16-28)23(25(30)36-14-12-34-10-5-2)22(21)18-7-6-8-19(15-18)27(31)32/h4,6-8,15,22,26,28H,1,5,9-14,16H2,2-3H3</moldb-inchi>
  <moldb-inchikey>CIRHYDJLUFGXCX-UHFFFAOYSA-N</moldb-inchikey>
  <moldb-average-mass type="decimal" nil="true"/>
  <moldb-mono-mass type="decimal">504.2107806</moldb-mono-mass>
  <origin nil="true"/>
  <state nil="true"/>
  <logp>2.4</logp>
  <hmdb-id nil="true"/>
  <chembl-id nil="true"/>
  <chemspider-id nil="true"/>
  <structure-image-file-name nil="true"/>
  <structure-image-content-type nil="true"/>
  <structure-image-file-size type="integer" nil="true"/>
  <structure-image-updated-at type="dateTime" nil="true"/>
  <biodb-id nil="true"/>
  <synthesis-reference nil="true"/>
  <structure-image-caption nil="true"/>
  <chemdb-id>CHEM338768</chemdb-id>
  <dsstox-id nil="true"/>
  <toxcast-id nil="true"/>
  <stoff-ident-origin nil="true"/>
  <stoff-ident-id nil="true"/>
  <susdat-id nil="true"/>
  <iupac>5-o-(2-prop-2-enoxyethyl) 3-o-(2-propoxyethyl) 2-(hydroxymethyl)-6-methyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate</iupac>
  <moldb-polar-surface-area nil="true"/>
  <moldb-refractivity nil="true"/>
  <moldb-polarizability nil="true"/>
  <moldb-rotatable-bond-count nil="true"/>
  <moldb-acceptor-count nil="true"/>
  <moldb-donor-count nil="true"/>
  <moldb-pka-strongest-acidic nil="true"/>
  <moldb-pka-strongest-basic nil="true"/>
  <moldb-physiological-charge nil="true"/>
  <moldb-number-of-rings nil="true"/>
  <moldb-alogps-logp nil="true"/>
  <moldb-alogps-logs nil="true"/>
  <moldb-alogps-solubility nil="true"/>
  <kingdom>Organic compounds</kingdom>
  <superklass>Organoheterocyclic compounds</superklass>
  <klass>Pyridines and derivatives</klass>
  <subklass>Hydropyridines</subklass>
  <paper-count type="integer" nil="true"/>
  <sync-id>CED0293259</sync-id>
  <structure-inchikey>CIRHYDJLUFGXCX-UHFFFAOYSA-N</structure-inchikey>
  <structure-fingerprint>40100000000000000800000000000000070000000000000000002000000000000000002000000000000000000000000000000000000000000000000000000008000000000000000000080000000000020000000001300001000000000400000000020010000000600000203120000000000001008000000000000000400100001000048000000800000200000000000001000001000000010001000000021000000000040000000000200080000000000000000000080000000000000000000000000000000800020000000045001000000000800002000000200000000000000400000000000000040000000000400000800101000020080001000000000</structure-fingerprint>
  <structure-pattern-fingerprint>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</structure-pattern-fingerprint>
  <structure-pickle type="binary" encoding="base64">776t3gAAAAAQAAAAAwAAAAAAAAAkAAAAJQAAAIABBgBgAAAAAQMGAGAAAAAC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</structure-pickle>
  <structure-indexed-at type="dateTime">2026-09-19T05:42:23Z</structure-indexed-at>
</compound>
